We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.

Skip to main content

The Jackson Laboratory

Home

Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

Home
Conference Posters and Presentations
2024-AAI-poster_IL3-DRIVEN CROSSTALK OF T CELL AND BASOPHIL ENHANCES ANTITUMOR IMMUNITY

2024-AAI-poster_IL3-DRIVEN CROSSTALK OF T CELL AND BASOPHIL ENHANCES ANTITUMOR IMMUNITY

Published Date May 8, 2024

Previous Flipbook

Transitioning from Pine to Hard Wood- Ensuring Animal Welfare and Research Integrity at The Jackson Laboratory
Next Flipbook

2024-AAI-poster_Natural History study to characterize CC011Unc:J spontaneous Mouse Model of Colitis

Most Recent Flipbooks

4 months ago
Transitioning from Pine to Hard Wood- Ensuring Animal Welfare and Research Integrity at The Jackson Laboratory

Read Flipbook
4 months ago
2024-AAI-poster_Natural History study to characterize CC011Unc:J spontaneous Mouse Model of Colitis

Read Flipbook
4 months ago
2024-AAI-poster_Mouse models advancing immunology research at The Jackson Laboratory

Read Flipbook
4 months ago
2024-AAI-poster_C57BL:6J-Trex1em3Lutzy:J KO mouse as a type 1 IFN dependent model for SLE preclinical drug discovery

Read Flipbook
5 months ago
Poster: Translational Humanized Models for Immunotherapy Drug Development | CHI 2024

Read Flipbook
5 months ago
Poster: Translational Humanized Models for Immunotherapy Drug Development | Immuno 2024

Read Flipbook
5 months ago
Poster: Evaluating toxicity and efficacy of bispecific EGFRXCD3 T cell engager in solid tumor-bearing humanized animal model

Read Flipbook
5 months ago
Poster: Assessing impacts of tumor burden and CAR-T cell dosage on the toxicity and efficacy profile of CD19 CAR-T therapy in a PBMC Model

Read Flipbook
5 months ago
Poster: Modeling individual variability in CD19 CAR-T therapy - An in vivo study with PBMC-humanized mice

Read Flipbook
5 months ago
Poster: The NSG-Flt3KO; Tg(hFLT3LG) hIL15 mouse strain improves engraftment of innate immune cells post-CD34+ humanization

Read Flipbook
5 months ago
Poster: Establishing orthotopic renal cell carcinoma xenograft in PBMC-humanized immunodeficient NSG-MHC I:II double knock-out mice

Read Flipbook
5 months ago
Poster: Hu-mouse model to assess PBMC donor derived autologous CD19 CAR-Ts for efficacy against Raji tumors and related Cytokine Release

Read Flipbook
10 months ago
SITC 2023 Comparison of Blinatumomab and Biosimilar CD19xCD3 BiTE responses in PBMC-Humanized Mice Used as a Preclinical Lymphoma Mouse Mode

Read Flipbook
10 months ago
SITC 2023 PBMC Humanized Mouse Model with Clinical Relevance in Assessing the Safety Profile of 4-1BB Agonist, Urelumab, in 5 Donors

Read Flipbook
11 months ago
PEGS EU 2023 - A Novel, Translational Platform to Assess the Efficacy and Toxicity of Bispecific Antibodies

Read Flipbook
11 months ago
PEGS EU 2023 - Predicting the Clinical PK of Candidate Therapeutic Antibodies

Read Flipbook
11 months ago
PEGS EU 2023 - Translational Humanized Models for Immunotherapy Drug Development

Read Flipbook
12 months ago
2023 AALAS P403 Comparing tumor erosion rate following P16MC38 subcutaneous (SC) vs. mammary fat pad (MFP) injections

Read Flipbook
12 months ago
2023 AALAS P402 Evaluating sub-renal capsule cavity tumor growth in immunodeficient NSG-MHC I/II double knock-out mice

Read Flipbook
over 1 year ago
2023 AACR The use of PBMC humanized mice to test the efficacy and safety of antibody and cell-based cancer immunotherapeutics

Read Flipbook

Recommended for you

Return to Home

© The Jackson Laboratory